ask="0.90"
ask_size="2000"
average_daily_volume="631225"
bid="0.70"
bid_size="6000"
book_value="0.61"
change="+0.01"
change_from_200_day_moving_average="-0.91"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-4.06"
change_From_52_week_low="0.37"
change_in_percent="+1.64%"
close="0.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.24"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="0.20"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.87"
high_52_weeks="4.93"
last_trade_date="3/15/2017"
last_trade_price="0.87"
last_trade_size="933"
last_trade_time="4:00pm"
low="0.73"
low_52_weeks="0.50"
market_capitalization="6.21M"
moving_average_200_day="1.78"
moving_average_50_day="0.99"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.80"
open="0.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-51.18%"
percent_change_from_50_day_moving_average="-11.76%"
percent_change_from_52_week_high="-82.35%"
percent_change_from_52_week_low="+74.00%"
previous_close="0.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.41"
price_per_sales="2.39"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.24"
stock_exchange="NCM"
symbol="OPXA"
volume="276033"
weeks_range_52="0.50 - 4.93"
